Inactive Instrument

Press Releases Inspyr Therapeutics, Inc. Other OTC

Equities

NSPX

US45782A4031

Press Releases

Unlock all the news: Be the first to know and act before the market!

REBUS HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-03-31	AQ
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	22-11-21	AQ
REBUS HOLDINGS, INC. : Changes in Registrant's Certifying Accountant (form 8-K)	22-11-16	AQ
REBUS HOLDINGS, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	22-10-13	AQ
Rebus : Quarterly Report for Quarter Ending June 30, 2022 (Form 10-Q)	22-08-12	PU
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	22-08-12	AQ
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	22-05-13	AQ
REBUS HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	22-03-31	AQ
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	21-11-12	AQ
Inspyr Therapeutics : Material Event - Form 8-K/A	21-10-12	PU
INSPYR THERAPEUTICS : Form 8-K	21-10-12	PU
INSPYR THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	21-10-12	AQ
Inspyr Therapeutics : AGREEMENT AND PLAN OF MERGER (Form 8-K)	21-10-05	PU
INSPYR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	21-10-05	AQ
Inspyr Therapeutics : NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	21-08-16	AQ
Inspyr Therapeutics : SENIOR CONVERTIBLE DEBENTURE DUE JUNE 18, 2022 (Form 8-K)	21-06-21	PU
INSPYR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	21-06-21	AQ
Inspyr Therapeutics : NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	21-05-17	AQ
INSPYR THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	21-03-31	AQ
INSPYR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	21-01-12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Inspyr Therapeutics, Inc. Other OTC

Equities

NSPX

US45782A4031

Press Releases

Filters